Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   gangliocytoma
  

Disease ID 1377
Disease gangliocytoma
Definition
A benign neoplasm that usually arises from the sympathetic trunk in the mediastinum. Histologic features include spindle cell proliferation (resembling a neurofibroma) and the presence of large ganglion cells. The tumor may present clinically with HORNER SYNDROME or diarrhea due to ectopic production of vasoactive intestinal peptide. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p966)
Synonym
gangliocytoma (morphologic abnormality)
gangliocytomas
ganglioneurofibroma
ganglioneuroma
ganglioneuroma (disorder)
ganglioneuroma (morphologic abnormality)
ganglioneuroma (schwannian stroma-dominant)
ganglioneuroma [disease/finding]
ganglioneuroma [dup] (morphologic abnormality)
ganglioneuroma, benign
ganglioneuromas
neural crest tumor, benign
Orphanet
DOID
UMLS
C0017075
MeSH
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:23)
C0032000  |  pituitary adenoma  |  6
C0001430  |  adenoma  |  5
C0032000  |  pituitary adenomas  |  4
C0085113  |  neurofibromatosis  |  4
C0030421  |  paraganglioma  |  2
C0031511  |  pheochromocytoma  |  2
C0001206  |  acromegaly  |  2
C0027819  |  neuroblastomas  |  2
C0001418  |  adenocarcinoma  |  1
C0206718  |  ganglioneuroblastomas  |  1
C0205698  |  undifferentiated carcinoma  |  1
C0221406  |  cushing's disease  |  1
C0023798  |  lipoma  |  1
C0751690  |  malignant peripheral nerve sheath tumor  |  1
C0010481  |  cushing's syndrome  |  1
C0346302  |  gh-secreting pituitary adenoma  |  1
C0345893  |  juvenile polyposis syndrome  |  1
C0023798  |  lipomas  |  1
C0345893  |  juvenile polyposis  |  1
C0032460  |  polycystic ovarian disease  |  1
C0041408  |  turner syndrome  |  1
C0206654  |  leiomyomatosis  |  1
C0494165  |  hepatic metastasis  |  1
Curated Gene(Waiting for update.)
Inferring Gene(Waiting for update.)
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:51)
116  |  ADCYAP1  |  1.04  |  DISEASES
171023  |  ASXL1  |  1.883  |  DISEASES
54880  |  BCOR  |  2.306  |  DISEASES
801  |  CALM1  |  1.522  |  DISEASES
841  |  CASP8  |  1.643  |  DISEASES
1621  |  DBH  |  1.149  |  DISEASES
2173  |  FABP7  |  1.675  |  DISEASES
2526  |  FUT4  |  1.084  |  DISEASES
85569  |  GALP  |  3.084  |  DISEASES
8811  |  GALR2  |  1.869  |  DISEASES
2520  |  GAST  |  2.013  |  DISEASES
9402  |  GRAP2  |  1.511  |  DISEASES
26762  |  HAVCR1  |  1.345  |  DISEASES
9118  |  INA  |  1.944  |  DISEASES
3831  |  KLC1  |  1.895  |  DISEASES
116372  |  LYPD1  |  2.353  |  DISEASES
4288  |  MKI67  |  1.045  |  DISEASES
23164  |  MPRIP  |  3.241  |  DISEASES
4535  |  MT-ND1  |  1.909  |  DISEASES
4763  |  NF1  |  3.792  |  DISEASES
4771  |  NF2  |  1.131  |  DISEASES
4803  |  NGF  |  2.524  |  DISEASES
344022  |  NOTO  |  1.944  |  DISEASES
594857  |  NPS  |  1.459  |  DISEASES
4886  |  NPY1R  |  1.664  |  DISEASES
4914  |  NTRK1  |  3.607  |  DISEASES
10215  |  OLIG2  |  1.608  |  DISEASES
5081  |  PAX7  |  1.107  |  DISEASES
5725  |  PTBP1  |  1.866  |  DISEASES
5728  |  PTEN  |  6.108  |  DISEASES
5728  |  PTEN  |  1.571  |  DISEASES
5789  |  PTPRD  |  1.57  |  DISEASES
146713  |  RBFOX3  |  3.351  |  DISEASES
146713  |  RBFOX3  |  1.346  |  DISEASES
8434  |  RECK  |  1.241  |  DISEASES
5979  |  RET  |  2.512  |  DISEASES
6295  |  SAG  |  1.128  |  DISEASES
6390  |  SDHB  |  2.176  |  DISEASES
6391  |  SDHC  |  2.35  |  DISEASES
6392  |  SDHD  |  2.209  |  DISEASES
6513  |  SLC2A1  |  1.875  |  DISEASES
6752  |  SSTR2  |  1.349  |  DISEASES
51684  |  SUFU  |  1.932  |  DISEASES
6863  |  TAC1  |  1.195  |  DISEASES
7021  |  TFAP2B  |  1.81  |  DISEASES
7033  |  TFF3  |  1.386  |  DISEASES
100507588  |  TGFBR3L  |  4.208  |  DISEASES
7054  |  TH  |  2.49  |  DISEASES
10381  |  TUBB3  |  2.016  |  DISEASES
10381  |  TUBB3  |  1.472  |  DISEASES
7432  |  VIP  |  4.49  |  DISEASES
Locus(Waiting for update.)
Disease ID 1377
Disease gangliocytoma
Integrated Phenotype
HPO | Name(Total Integrated Phenotypes:26)
HP:0001317  |  Abnormality of the cerebellum
HP:0000845  |  Growth hormone excess
HP:0003005  |  Ganglioneuroma
HP:0011761  |  Pituitary null cell adenoma
HP:0001262  |  Excessive daytime somnolence
HP:0002591  |  Polyphagia
HP:0003401  |  Paresthesia
HP:0040086  |  Abnormal prolactin level
HP:0010302  |  Spinal cord tumor
HP:0003396  |  Syringomyelia
HP:0006767  |  Pituitary prolactin cell adenoma
HP:0007359  |  Focal seizures
HP:0000975  |  Hyperhidrosis
HP:0002650  |  Scoliosis
HP:0000726  |  Dementia
HP:0002363  |  Abnormality of brainstem morphology
HP:0011749  |  Adrenocorticotropic hormone excess
HP:0005616  |  Accelerated skeletal maturation
HP:0000802  |  Impotence
HP:0012377  |  Hemianopsia
HP:0000141  |  Amenorrhea
HP:0030018  |  Decreased female libido
HP:0012503  |  Abnormality of the pituitary gland
HP:0002460  |  Distal muscle weakness
HP:0100006  |  Neoplasm of the central nervous system
HP:0002315  |  Headache
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:10)
HP:0002893  |  Pituitary adenoma  |  6
HP:0001067  |  Neurofibromas  |  5
HP:0002664  |  Neoplasia  |  3
HP:0002666  |  Pheochromocytoma  |  3
HP:0002668  |  Paragangliomas  |  2
HP:0000845  |  Acromegalic growth  |  2
HP:0012032  |  Lipoma  |  1
HP:0007332  |  Hemifacial seizures  |  1
HP:0100697  |  Neurofibrosarcoma  |  1
HP:0001250  |  Seizures  |  1
Disease ID 1377
Disease gangliocytoma
Manually Symptom
UMLS  | Name(Total Manually Symptoms:2)
C0431380  |  cortical dysplasia
C0001206  |  acromegaly
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:2)
C0001206  |  acromegaly  |  1
C1608408  |  malignant transformation  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:0)
(Waiting for update.)
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:9)
HP ID HP Name MP ID MP Name Annotation
HP:0000845Growth hormone excessMP:0003497insensitivity to parathyroid hormoneno changes in calcium homeostasis in response to endogenous or exogenous hormone
HP:0002363Abnormality of brainstem morphologyMP:0004568fusion of glossopharyngeal and vagus nerveunion of the ninth and tenth cranial nerves into a single structure
HP:0011749Adrenocorticotropic hormone excessMP:0005418abnormal circulating hormone levelany anomaly in the blood concentration of any of the chemical substances that have specific regulatory effects on the activity of a certain organ or organs; originally applied to substances secreted by various endocrine glands and transported in the blood
HP:0100006Neoplasm of the central nervous systemMP:0005387immune system phenotype
HP:0007359Focal seizuresMP:0009358environmentally induced seizuresseizure activity response due to changes in ambient habitat including room temperature, lighting, sounds, touching, and/ or moving cage
HP:0006767Pituitary prolactin cell adenomaMP:0013383increased sebaceous gland adenoma incidencegreater than the expected number of a benign epithelial neoplasm with a glandular organization arising in any sebaceous gland, occurring in a specific population in a given time period
HP:0005616Accelerated skeletal maturationMP:0003378early sexual maturationpubertal changes occur at an earlier than normal age
HP:0002460Distal muscle weaknessMP:0000748progressive muscle weaknessincreasing loss of muscle strength over time
HP:0010302Spinal cord tumorMP:0009277increased brain tumor incidencegreater than the expected number of abnormal rapidly proliferating cells in the brain, usually in the form of a distinct mass, occurring in a specific population in a given time period
Mapped by homologous gene(Total Items:22)
HP ID HP Name MP ID MP Name Annotation
HP:0002650ScoliosisMP:0020309increased creatine kinase activityincreased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+).
HP:0000845Growth hormone excessMP:0014169decreased brown adipose tissue massdecreased physical bulk or volume of brown adipose tissue
HP:0002315HeadacheMP:0020137decreased bone mineralizationdecrease in the rate at which minerals are deposited into bone
HP:0000802ImpotenceMP:0012504increased forebrain apoptosisincrease in the number of cells of the forebrain undergoing programmed cell death
HP:0005616Accelerated skeletal maturationMP:0020010decreased bone mineral density of femurreduction in the quatitative measurment value of mineral content of bone in the long bone of the thigh
HP:0003401ParesthesiaMP:0014185cerebellum atrophyacquired diminution of the size of the cerebellum associated with wasting as from death and reabsorption of cells, diminished cellular proliferation, decreased cellular volume, pressure, ischemia, malnutrition, reduced function or malfunction, or hormonal
HP:0012377HemianopiaMP:0013405increased circulating lactate levelgreater amount of lactate in the blood which is produced from pyruvate by lactate dehydrogenase
HP:0002591PolyphagiaMP:0020329decreased capillary densityreduction in the number of capillaries in a given cross-sectional area of a tissue
HP:0010302Spinal cord tumorMP:0013611abnormal bile duct epithelium morphologyany structural anomaly of the epithelium lining the intrahepatic and extrahepatic bile ducts
HP:0001317Abnormality of the cerebellumMP:0011971increased circulating lactate dehydrogenase levelelevated blood level of the tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of lactate and pyruvate; measurements of circulating levels are used clinically as a diagnostic indicator of tissue breakdown, some forms of ca
HP:0007359Focal seizuresMP:0020160abnormal behavioral response to nicotineany anomaly in the behavioral response induced by nicotine, such as induced hyperactivity or stereotypic behavior
HP:0006767Pituitary prolactin cell adenomaMP:0014167ectopic bonethe appearance of an extra bone structure at an atypical location
HP:0000975HyperhidrosisMP:0020187altered susceptibility to prion infectionaltered likelihood that an organism will develop ill effects from the small proteinaceous infectious particles which are resistant to inactivation by procedures that modify nucleic acids and which contain an abnormal isoform of a cellular protein that is
HP:0011749Adrenocorticotropic hormone excessMP:0011088neonatal lethality, incomplete penetrancethe appearance of lower than Mendelian ratios of organisms of a given genotype due to death of some, but not all of the organisms within the neonatal period after birth (Mus: P0)
HP:0001262SomnolenceMP:0013504increased embryonic tissue cell apoptosisincrease in the timing or the number of cells in embryonic tissue undergoing programmed cell death
HP:0000726DementiaMP:0020329decreased capillary densityreduction in the number of capillaries in a given cross-sectional area of a tissue
HP:0003005GanglioneuromaMP:0013795abnormal colon goblet cell morphologyany structural anomaly of the glandular simple columnar epithelial cell found in the mucosal lining of the colon, whose primary function is to secrete gel-forming mucins, the major components of mucus
HP:0002363Abnormality of brainstem morphologyMP:0012817rhombomere fusionthe union of one or more rhombomeres into a single structure
HP:0000141AmenorrheaMP:0013395eyelid hypoplasiaunderdevelopment or reduced size of the skin folds covering the front of the eyeball, usually due to a decreased cell number
HP:0100006Neoplasm of the central nervous systemMP:0014126increased mammary gland apoptosisincrease in the number of any cells of a mammary gland undergoing programmed cell death
HP:0002460Distal muscle weaknessMP:0020220decreased tear productiondecreased production of the amount of fluid produced in the eye
HP:0003396SyringomyeliaMP:0020254decreased collagen leveldecreased level of the main structural protein of the various connective tissues in animals
Disease ID 1377
Disease gangliocytoma
Case(Waiting for update.)